Insider trades
Carole Ben-Maimon, CEO of Larimar Therapeutics LRMR, has filed 1 purchase and 0 sales on the open market. The latest trade was on 01/26.
Carole Ben-Maimon
President and CEO
- Company
- Larimar Therapeutics LRMR
- First filing
- 23/02/02
- Trades
- 9 trades
- Buys / sales
- 1 / 0
- 12-month net buying
- No record
- Last trade
- 01/26
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 23/05/17 | 23/05/18 | 5,000 sh | $3.71 | $18,550 | +1.9% |